Physician profile
Jason Hoops
NPI 1003571217
$238.32
in general payments reported to CMS, 2019-2025
9 companies · $52.75 in 2025
The $52.75 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $116 · 2024: $69.93 · 2025: $52.75.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $238.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $238.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Sales INC. | $50.73 | 2023-2025 | Orthovisc, Monovisc |
| Pacira Pharmaceuticals Incorporated | $44.12 | 2023-2025 | Zilretta, Iovera, Exparel |
| Ibsa Pharma INC. | $40.36 | 2023-2024 | Tirosint, Licart, Licart |
| Orthofix Medical, INC. | $18.62 | 2023 | Physio-Stim |
| Vertex Pharmaceuticals Incorporated | $18.43 | 2024 | |
| Zimmer Biomet Holdings, INC. | $17.41 | 2024 | Gel-One Cross-Linked Hyaluronate |
| Endo Pharmaceuticals INC. | $16.91 | 2023 | Xiaflex |
| Kerecis Limited | $16.31 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Bioventus LLC | $15.43 | 2024 | Exogen Ultrasound Bone Healing System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jason Hoops listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.